GENE ONLINE|News &
Opinion
Blog

Cancer
Priority Review of Seagen’s Colorectal Cancer Treatment Wins FDA Acceptance
2022-09-19
Is Frozen-Thawed Embryo Transfer Associated with Increased Cancer Risk?
2022-09-16
Series D Funding Brings Radiopharmaceutical Company RayzeBio to $418 million in Total
2022-09-13
Incyte’s Rare Cancer Drug Snags Second FDA Approval
2022-08-29
NIH Provides $23 Million to Fund Telehealth Cancer Care Research
2022-08-22
Kyowa Kirin’s Treatment for a Rare Cancer Disorder Approved by European Commission
2022-08-19
Bayer, Orion’s Prostate Cancer Drug Gets Approval For Second Indication
2022-08-10
First Targeted Therapy for HER2-Low Breast Cancer Approved by FDA
2022-08-05
LOCOcyte – Avenge Bio’s Potential Treatment for Ovarian Cancer gets FDA Clearance
2022-08-03
Cancer Immunotherapy Phase III Trial Yields Positive Results
2022-08-02
AstraZeneca Calls Off Monalizumab Study With Innate After Phase 3 Disappoints
2022-08-02
Bristol Myers Squibb Provides an Update on Kidney Cancer Treatment
2022-08-01
Taiwan’s CancerFree Bio Showcases World’s First Commercialized Personalized Cancer Profile
2022-08-01
First Patient Dosed in Anti-tumor Clinical Trial
2022-07-29
Cancer Research UK and Sosei Heptares Set for First Human Trial of EP4 Antagonist
2022-07-22
1 2 3 4 22
LATEST
Innovative Cellular Mapping of BRCA-Related Breast Cancer Findings Reveals Novel Therapeutic Targets
2024-03-29
Previewing AACR 2024 With Select Pre-Meeting Highlights
2024-03-28
Roche Delivering on Malaria Screening Solutions for Blood Donation
2024-03-28
Innovating Cancer Treatment: The Role of ADC Technology at Nona Biosciences
2024-03-28
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Galderma’s Strong European IPO Debut
2024-03-26
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top